Gordon Lavigne, MEd

home / authors / gordon-lavigne-med

Mr Lavigne is the chief executive officer of the Schizophrenia & Psychosis Action Alliance.

Articles

Advocacy Group Applaud Joint FDA Committee Proposed Changes to Clozapine REMS Requirements

Advocacy Group Applaud Joint FDA Committee Proposed Changes to Clozapine REMS Requirements

Heidi Anne Duerr, MPH;Gordon Lavigne, MEd

November 26th 2024

Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: November 26th 2024

Mini Quiz: Treatment for Pedophilia?

Mini Quiz: Medical Catatonia

Published: May 12th 2017 | Updated: November 26th 2024

Mini Quiz: Medical Catatonia

Poor DSM-5—So Misunderstood!

Published: March 23rd 2021 | Updated: November 26th 2024

Poor DSM-5—So Misunderstood!

Mini Quiz: Characterizing Sexual Deviation

Published: January 23rd 2017 | Updated: November 26th 2024

Mini Quiz: Characterizing Sexual Deviation

Mini Quiz: Assessment of Malingering

Published: April 1st 2019 | Updated: November 26th 2024

Mini Quiz: Assessment of Malingering

Mini Quiz: Methods of Suicide

Published: January 21st 2016 | Updated: November 26th 2024

Mini Quiz: Methods of Suicide

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.